892 related articles for article (PubMed ID: 19584287)
41. The mitotic kinase Aurora-A induces mammary cell migration and breast cancer metastasis by activating the Cofilin-F-actin pathway.
Wang LH; Xiang J; Yan M; Zhang Y; Zhao Y; Yue CF; Xu J; Zheng FM; Chen JN; Kang Z; Chen TS; Xing D; Liu Q
Cancer Res; 2010 Nov; 70(22):9118-28. PubMed ID: 21045147
[TBL] [Abstract][Full Text] [Related]
42. Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential.
Zhuang ZG; Di GH; Shen ZZ; Ding J; Shao ZM
Mol Cancer Res; 2006 Nov; 4(11):843-9. PubMed ID: 17114342
[TBL] [Abstract][Full Text] [Related]
43. Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis.
Dutertre M; Lacroix-Triki M; Driouch K; de la Grange P; Gratadou L; Beck S; Millevoi S; Tazi J; Lidereau R; Vagner S; Auboeuf D
Cancer Res; 2010 Feb; 70(3):896-905. PubMed ID: 20103641
[TBL] [Abstract][Full Text] [Related]
44. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
Ursini-Siegel J; Rajput AB; Lu H; Sanguin-Gendreau V; Zuo D; Papavasiliou V; Lavoie C; Turpin J; Cianflone K; Huntsman DG; Muller WJ
Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
[TBL] [Abstract][Full Text] [Related]
45. Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells.
Aalinkeel R; Nair MP; Sufrin G; Mahajan SD; Chadha KC; Chawda RP; Schwartz SA
Cancer Res; 2004 Aug; 64(15):5311-21. PubMed ID: 15289337
[TBL] [Abstract][Full Text] [Related]
46. Stimulation of cultured colon 26 cells with TNF-alpha promotes lung metastasis through the extracellular signal-regulated kinase pathway.
Choo MK; Sakurai H; Koizumi K; Saiki I
Cancer Lett; 2005 Dec; 230(1):47-56. PubMed ID: 16253760
[TBL] [Abstract][Full Text] [Related]
47. The low-density lipoprotein receptor-related protein regulates cancer cell survival and metastasis development.
Montel V; Gaultier A; Lester RD; Campana WM; Gonias SL
Cancer Res; 2007 Oct; 67(20):9817-24. PubMed ID: 17942912
[TBL] [Abstract][Full Text] [Related]
48. Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines.
Euer N; Schwirzke M; Evtimova V; Burtscher H; Jarsch M; Tarin D; Weidle UH
Anticancer Res; 2002; 22(2A):733-40. PubMed ID: 12014644
[TBL] [Abstract][Full Text] [Related]
49. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
[TBL] [Abstract][Full Text] [Related]
50. Osteoactivin promotes breast cancer metastasis to bone.
Rose AA; Pepin F; Russo C; Abou Khalil JE; Hallett M; Siegel PM
Mol Cancer Res; 2007 Oct; 5(10):1001-14. PubMed ID: 17951401
[TBL] [Abstract][Full Text] [Related]
51. Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells.
Croci S; Nicoletti G; Landuzzi L; Palladini A; Chiarini F; Nanni P; Lollini PL; De Giovanni C
Oncol Rep; 2007 Aug; 18(2):451-6. PubMed ID: 17611670
[TBL] [Abstract][Full Text] [Related]
52. p75 neurotrophin receptor inhibits invasion and metastasis of gastric cancer.
Jin H; Pan Y; He L; Zhai H; Li X; Zhao L; Sun L; Liu J; Hong L; Song J; Xie H; Gao J; Han S; Li Y; Fan D
Mol Cancer Res; 2007 May; 5(5):423-33. PubMed ID: 17510309
[TBL] [Abstract][Full Text] [Related]
53. Tumor-derived CCL5 does not contribute to breast cancer progression.
Jayasinghe MM; Golden JM; Nair P; O'Donnell CM; Werner MT; Kurt RA
Breast Cancer Res Treat; 2008 Oct; 111(3):511-21. PubMed ID: 17978871
[TBL] [Abstract][Full Text] [Related]
54. Plasminogen activators and inhibitors in the neuromuscular system: III. The serpin protease nexin I is synthesized by muscle and localized at neuromuscular synapses.
Festoff BW; Rao JS; Hantaï D
J Cell Physiol; 1991 Apr; 147(1):76-86. PubMed ID: 2037625
[TBL] [Abstract][Full Text] [Related]
55. Using caffeoyl pyrrolidine derivative LY52, a potential inhibitor of matrix metalloproteinase-2, to suppress tumor invasion and metastasis.
Qu XJ; Yuan YX; Tian ZG; Xu WF; Chen MH; Cui SX; Guo Q; Gai R; Makuuchi M; Nakata M; Tang W
Int J Mol Med; 2006 Oct; 18(4):609-14. PubMed ID: 16964412
[TBL] [Abstract][Full Text] [Related]
56. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
[TBL] [Abstract][Full Text] [Related]
57. Role of matrix metalloproteinase-2 in ethanol-induced invasion by breast cancer cells.
Luo J
J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S65-8. PubMed ID: 16958676
[TBL] [Abstract][Full Text] [Related]
58. Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas.
Jiang XP; Elliott RL; Head JF
Anticancer Res; 2010 Mar; 30(3):759-65. PubMed ID: 20392994
[TBL] [Abstract][Full Text] [Related]
59. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.
Overall CM; Tam EM; Kappelhoff R; Connor A; Ewart T; Morrison CJ; Puente X; López-Otín C; Seth A
Biol Chem; 2004 Jun; 385(6):493-504. PubMed ID: 15255181
[TBL] [Abstract][Full Text] [Related]
60. RNA interference inhibition of matrix metalloproteinase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis.
Blackburn JS; Rhodes CH; Coon CI; Brinckerhoff CE
Cancer Res; 2007 Nov; 67(22):10849-58. PubMed ID: 18006830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
